Funding agencies and institutions in many countries increasingly require evidence of societal impact alongside traditional academic metrics. Global media coverage of your published research provides exactly that evidence, while simultaneously driving the citations and visibility that advance your career.
Visibility drives citations. A paper that reaches millions through major news outlets does not sit unread in a database. It gets noticed, shared, discussed, and cited. Media attention accelerates every metric that matters: citations, Impact Factor contributions, and documented societal reach for grant applications and promotion portfolios.
Genomic Press has built a global dissemination infrastructure that no other publisher matches, and it is included with every publication at no additional cost.
Every paper receives a professionally written press release distributed through EurekAlert! (AAAS), the AAAS platform that reaches 12,000+ science journalists worldwide. These releases go out in seven languages: English, German, French, Spanish, Portuguese, Japanese, and Chinese, collectively spoken by over 40% of the world population. This multilingual strategy is what drives original reporting in outlets such as Nature, The New York Times, Washington Post, CNN, BBC, El País, Frankfurter Allgemeine Zeitung, Corriere della Sera, South China Morning Post, and hundreds more.
For most papers, we also distribute through EIN Presswire, which places your research across hundreds of US news platforms, including NBC, CBS, FOX, and ABC affiliates nationwide, and into professional databases including Bloomberg Terminal and Moody’s Analytics. In 2025 alone, this resulted in over 20 syndications through the Associated Press (AP), the global news agency whose content is republished by 15,000+ newspapers, broadcasters, and digital outlets worldwide, reaching an estimated 4 billion people daily. More than 30 of our papers have appeared on MSN.com, Microsoft’s news portal that serves as the default start page for the Microsoft Edge browser on every Windows computer worldwide, drawing 1.3 billion monthly visitors. Critically, EIN distribution also feeds directly into AI databases, including Google, ChatGPT, Gemini, and Perplexity. This matters because a growing number of people now receive their news through personalized AI-curated feeds, and this distribution pipeline places your research directly into the stream of content those AI systems serve to their users.
Genomic Press has also established deep reach into China, where a distinct digital ecosystem serves over a billion users. Our research has been featured on NetEase (163.com), one of China's largest news portals and its most popular personal email provider; Tencent QQ News, reaching billions; Huxiu (虎嗅网), a leading technology and business platform; Guancha.cn (观察者网); China.com (中华网); MIT Technology Review China; China Science Daily (科学网); Zhihu (知乎), China's dominant academic Q&A platform; and Sina Finance. For Chinese researchers, this domestic visibility carries the same career weight as a feature in the New York Times or BBC carries in the West.
This combined approach has generated 5,000+ news stories across 45+ languages, attaining a global media reach of 1.6 billion+ from just three journals in one year.
All Genomic Press authors also receive access to Altmetric, a professional tool for tracking your paper’s social media and news footprint in real time. Altmetric provides a valuable baseline measure of attention, though it does not capture the full scope of global media impact, particularly international press coverage, which often extends well beyond what any single tracking platform can detect. The true reach of your work is typically much greater.
We do not just publish your breakthrough. We make it impossible to ignore.
